Vimarsana
Biggest News Aggregation in the World

Page 16 - Technology General News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Technology General. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Technology General Today - Breaking & Trending Today

Artificial Intelligence will not save banks from short-sightedness - Vimarsana News

Artificial Intelligence will not save banks from short-sightedness

Banks like Credit Suisse use sophisticated models to analyse and predict risks, but too often they are ignored or bypassed by humans.

Switzerland posts strong patent growth in 2022 - Vimarsana News

Switzerland posts strong patent growth in 2022

Swiss companies and inventors filed 9,008 patent applications at the European Patent Office (EPO) in 2022, an increase of 5.9% compared to 2021. Switzerland is ranked seventh among the top ten countries with the most patent applications last year. In terms of patent applications per capita, Switzerland remains the leading country (1,031 per million inhabitants), followed by Nordic states, according to the EPO's Patent Index 2022 released on Tuesday. Overall, the EPO received 193,460 patent applications last year, an increase of 2.5% on the previous year and a new record. This follows an increa...

Power-generating railway tracks are coming down the line - Vimarsana News

Power-generating railway tracks are coming down the line

Swiss start-up Sun-Ways has developed a mechanical system to install removable solar panels along railway tracks.

Legal gaps hamper Big Data's benefits, finds study - Vimarsana News

Legal gaps hamper Big Data's benefits, finds study

A national research program investigating Big Data’s role in society has reinforced calls to update regulation to ensure responsible use of the technology.

Recursion Provides Business Updates and Reports Fourth - Vimarsana News

Recursion Provides Business Updates and Reports Fourth

Initiated five clinical trials in 2022, including three Phase 2 programs, and provided guidance on the timing of clinical data readoutsDelivered against...